Results 51 to 60 of about 625 (141)

DeepNAPSI multi-reader nail psoriasis prediction using deep learning

Scientific Reports, 2023
Nail psoriasis occurs in about every second psoriasis patient. Both, finger and toe nails can be affected and also severely destroyed. Furthermore, nail psoriasis is associated with a more severe course of the disease and the development of psoriatic ...
Lukas Folle, Pauline Fenzl, Filippo Fagni, Mareike Thies, Vincent Christlein, Christine Meder, David Simon, Ioanna Minopoulou, Michael Sticherling, Georg Schett, Andreas Maier, Arnd Kleyer   +11 more
doaj   +1 more source

Marine‐Derived Biomaterials in Psoriasis Treatment: Therapeutic Potential and Development Perspectives

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Psoriasis is a multifactorial skin disease characterized by inflamed, scaly lesions arising from abnormal keratinocytes proliferation and immune dysregulation. Its persistent and relapsing nature underscores the need for long‐term treatment, making natural products increasingly attractive as alternative therapeutic options.
Tri Purwa Ningrum, Nguyen Vu Linh, Fazlurrahman Khan, Young-Mog Kim, Hyun-Woo Kim, Jae-Young Je, Woo-Ram Um, Won Sun Park, Tae-Hee Kim, Won-Kyo Jung   +9 more
wiley   +1 more source

Long‐Term Clinical Outcomes of Guselkumab in Patients With Plaque Psoriasis and Concomitant Psoriatic Arthritis: A 76‐Week Real‐World Cohort Study

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Background Guselkumab is a selective monoclonal antibody targeting the interleukin‐23 (IL‐23) p19 subunit and is approved for the treatment of moderate‐to‐severe plaque psoriasis. Although randomized clinical trials have demonstrated its efficacy and safety, real‐world evidence remains essential to evaluate treatment performance in routine clinical ...
Meltem Turkmen, Sinan Dogan, Emre Sarıkaya, Suraiya Saleem   +3 more
wiley   +1 more source

Microscopic Examination of Nail Clippings from Patients with Palmoplantar Pustulosis

Dermatopathology, 2019
This study describes the clinical characteristics and microscopic findings of nails from 25 patients with palmoplantar pustulosis. Methods: This is a cross-sectional study of adult patients with clear-cut palmoplantar pustulosis. Onychodystrophy severity
Anber Ancel Tanaka, Betina Werner, Cassia Farris, Cassio Tornesy   +3 more
doaj   +1 more source

Smoking and Nail Psoriasis: Examining the Connection in a Case‐Control Study

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Background Nail psoriasis (NP) significantly affects patients’ quality of life and is associated with psoriasis severity. Smoking is a preventable risk factor that has been tied to poor disease outcomes, but its effect on NP is not well established. The purpose of this work is to analyze the connection between smoking and NP severity and occurrence ...
Safoura Shakoei, Fatemeh Heidari, Maryam Nasimi, Shahin Hamzelou, Fatemeh Saberi, Hanie Babaie, Yung-Tsu Cho   +6 more
wiley   +1 more source

ONICOMICOSE EM DOENTES COM PSORÍASE – UMA ENTIDADE SUBESTIMADA?

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2015
Introdução: As alterações ungueais em doentes com psoríase podem decorrer ou agravar-se mediante infecção fúngica, cujo risco se poderá encontrar aumentado decorrente de terapêuticas imunossupressoras e alterações estruturais do prato ungueal.
Ana Brasileiro, Célia Galhardas, Ana Fidalgo, Margarida Apetato   +3 more
doaj   +1 more source

A Common Genetic Background for Psoriasis and Cardiovascular Diseases: A Narrative Review

Health Science Reports, Volume 8, Issue 8, August 2025.
ABSTRACT Background and Aims Psoriasis is an immune‐mediated disease affecting primarily the skin and joints, but which also has systemic implications. There are assumptions about a common genetic background between psoriasis and cardiovascular diseases.
Andrada‐Luciana Lazar, Cleopatra Romana Vulturar, Adela‐Viviana Sitar‐Tăut, Ramona Suharoschi, Olga Hilda Orășan, Adina Ancuța Chiș, Adriana Fodor, Brîndușa Tiperciuc, Cezar Login, Angela Cozma   +9 more
wiley   +1 more source

Psoriasis ungueal y riesgo cardiovascular: una revisión narrativa sobre disfunción endotelial, inflamación e índice NAPSI

Revista de la Sociedad Peruana de Medicina Interna
Introducción: La psoriasis ungueal es una manifestación frecuente y clínicamente relevante de la psoriasis, que puede presentarse incluso en ausencia de lesiones cutáneas. Dado el impacto de la semiología del paciente con psoriasis, se ha propuesto como una oportunidad pragmática para detectar pacientes con mayor probabilidad de disfunción endotelial y
Kelly Johana Aragón-Nariño, Yuleidys Acosta-Guzmán, Maria Mercedes Menco-Menco, Diana Parra-Moreno, Riguey Mercado-Marchena, Maria Paula Quintero-Uribe   +5 more
openaire   +1 more source

Psoriasis in People With Skin of Color: An Evidence‐Based Update

International Journal of Dermatology, Volume 64, Issue 4, Page 667-677, April 2025.
ABSTRACT Variations in epidemiology, pathophysiology, genetics, clinical presentation, management, quality of life (QoL) impact, and access to care and research exist globally across the spectrum of individuals with psoriasis. This article aims to provide an evidence‐based update on the characteristics of psoriasis in individuals with skin of color ...
Maria‐Angeliki Gkini, Mio Nakamura, Andrew F. Alexis, Angela Londoño‐Garcia, Peter C. M. van de Kerkhof, Nejib Doss, Christopher E. M. Griffiths, Bridget Kaufman, Christine E. Kleyn, Mark Lebwohl, Jan S. Redfern, Junko Takeshita, Murlidhar Rajagopalan, Mahira H. El Sayed   +13 more
wiley   +1 more source

Effectiveness, safety and quality‐of‐life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non‐interventional, prospective, German multicentre PERSIST study

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue S1, Page 38-49, March 2025.
Abstract Background PERSIST was a prospective, non‐interventional, real‐world study of guselkumab and ustekinumab in adult patients with moderate‐to‐severe plaque psoriasis in Germany. Objectives To examine effectiveness, safety and quality‐of‐life (QoL) outcomes to Week (W) 104 of treatment with guselkumab and ustekinumab in patients with moderate‐to ...
S. Gerdes, M. Hoffmann, K. Asadullah, B. Korge, D. Mortazawi, N. Krüger, Y. Personke, S. Tabori, M. Gomez, S. Wegner, F. Kreimendahl, F. Taut, M. Sticherling   +12 more
wiley   +1 more source